FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly to ophthalmology. Retinopathy stage IV-V diagnostic technique is ensured as follows. Birth body weight is measured with estimating application of erythrocytic mass transfusion, estimating type of infant feeding and delivery, 1-minute Apgar score, fraction of monocytes, birth body length, bilirubin level in blood serum. Herewith each considered indicator is specified with a diagnostic factor with informativity decrease. If erythrocytic mass transfusion is applied within 1-30 days of life, diagnostic factor is specified 0.41, otherwise diagnostic factor is (-)0.42. Breast feeding ensures diagnostic factor (-)0.43, while with artificial or mixed feeding diagnostic factor is 0.37. If 1-minute Apgar score is ≤5 points, diagnostic factor is 0.33, while Apgar score >5 points shows diagnostic factor (-)0.45. If monocyte fraction within 1-7 days of life is >15%, set diagnostic factor is 0.42, while monocyte fraction within 1-7 days of life ≤15% provides diagnostic factor (-)0.31. If natural delivery are applied, diagnostic factor is 0.31, and with operative delivery diagnostic factor is (-)0.37. If birth body weight is ≤1400 g, diagnostic factor is 0.30, and if birth body weight is >1400 g, diagnostic factor is
(-)0.35. In birth body length ≤40 cm diagnostic factor is 0.34, while in birth body length >40 cm, diagnostic factor is (-)0.29. Total bilirubin level within 1-7 days of life ≤130 mkmol/l provides diagnostic factor 0.29, while total bilirubin level within 1-7 days of life >130 mkmol/l ensures diagnostic factor (-)0.33. The correction is
(-)0.056. It is followed with calculating total diagnostic factor considering the correction. If total diagnostic factor with informativity decreasing at certain analysis is at least 0.68, retinopathy stage IV-V in premature infants is considered to be diagnosed. If total diagnostic factor is 1.2 and less, retinopathy stage IV-V in premature infants is considered not to be observed.
EFFECT: method improves reliability and simplifies diagnostics of retinopathy stage IV-V in premature infants that reduces probability of blindness in infants caused by early change in therapeutic tactics.
1 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
PREDICTION METHOD OF PREMATURE RETINOPATHY LASER COAGULATION USE | 2016 |
|
RU2621307C1 |
METHOD OF NEONATAL SEPTIS PREDICTION IN PREMATURE INFANTS | 2007 |
|
RU2358653C1 |
PERIVENTRICULAR LEUKOMALACIA DIAGNOSIS OF INFANCY WITH ISCHEMIC CEREBRAL AFFECTION | 2006 |
|
RU2325841C1 |
SPASTIC INFANTILE CEREBRAL PARALYSIS PREDICTION FOR PREMATURE CHILDREN | 2006 |
|
RU2325840C1 |
METHOD OF FORECASTING INFINTILE CEREBRAL PARALYSES IN MATURE BABIES | 2007 |
|
RU2357655C1 |
METHOD FOR PREDICTING THE FORMATION OF THE THRESHOLD STAGE OF RETINOPATHY OF PREMATURE INFANTS WITH EXTREMELY LOW BIRTH WEIGHT IN THE EARLY NEONATAL PERIOD | 2018 |
|
RU2677464C1 |
METHOD FOR PREDICTION OF DEVELOPMENT OF POSTERIOR AGGRESSIVE RETINOPATHY IN PREMATURE INFANTS | 2010 |
|
RU2441593C1 |
METHOD FOR PREDICTING RISK OF ISCHEMIC DAMAGE TO CENTRAL NERVOUS SYSTEM OF MODERATE AND SEVERE SEVERITY IN FULL-TERM NEWBORNS BORN BY CAESAREAN SECTION | 2020 |
|
RU2753820C1 |
METHOD OF PREDICTING DEVELOPMENT OF MULTIFACTOR PATHOLOGY IN CHILDREN BORN WITH APPLICATION OF AUXILIARY REPRODUCTIVE TECHNOLOGIES | 2011 |
|
RU2456911C1 |
METHOD FOR PREDICTING DEVELOPMENT OF THRESHOLD STAGE OF RETHINOPATHY OF PREMATURITY IN CHILDREN WITH EXTREMELY LOW WEIGHT | 2016 |
|
RU2641161C1 |
Authors
Dates
2009-06-20—Published
2007-12-26—Filed